Cem Dogan

Cem Dogan

Auto-generated profile, based on publicly available information

Cem Dogan

Univ Hlth Sci, Kartal Kosuyolu Training & Res Hosp, Dept Cardiol, Istanbul, Turkiye

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2022 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
HTHacer Ceren Tokgoz
Hacer Ceren Tokgoz
OAOzgur Yasar Akbal
Ozgur Yasar Akbal
AKAli Karagoz
Ali Karagoz
BKBarkın Kültürsay
Barkın Kültürsay
SÜSeda TANYERİ ÜZEL
Seda TANYERİ ÜZEL
CKCihangir Kaymaz
Cihangir Kaymaz
Pulmonary arterial hypertension,mortality,pregnancy

1 October 2022 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
CKCihangir Kaymaz
Cihangir Kaymaz
SÜSeda TANYERİ ÜZEL
Seda TANYERİ ÜZEL
HTHacer Ceren Tokgoz
Hacer Ceren Tokgoz
OAOzgur Yasar Akbal
Ozgur Yasar Akbal
AKAli Karagoz
Ali Karagoz
NONihal Ozdemir
Nihal Ozdemir
Macitentan,pulmonary arterial hypertension,Eisenmenger syndrome,REVEAL-Lite 2,COMPERA,SPAHR

3 June 2021 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
ZBZubeyde Bayram
Zubeyde Bayram
ITIstanbul- Turkey
Istanbul- Turkey
CDCem Dogan
Cem Dogan
RAREZZAN DENİZ ACAR
REZZAN DENİZ ACAR
SESuleyman Efe
Suleyman Efe
NONihal Ozdemir
Nihal Ozdemir
Objective: Increased pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR) are important prognostic factors in patients with heart transplantation (HT). It is well known that severe mitrel regurgitation increases pulmonary pressures. However, the European Society of Cardiology and the 6th World Symposium of pulmonary hypertension (PH) task force redefined severe functional mitral regurgitation (FMR) and PH, respectively. We aimed to investigate the effect of severe FMR on PAP and PVR based on these major redefinitions in patients with HT. Methods: A total of 212 patients with HT were divided into 2 groups: those with severe FMR (n=70) and without severe FMR (n=142). Severe FMR was defined as effective orifice regurgitation area >= 20 mm(2) and regurgitation volume >= 30 mL where the mitrel valve was morphologically normal. A mean PAP of >20 mm Hg was accepted as PH. Patients with left ventricular ejection fraction <= 25% were included in the study. Results: The systolic PAP, mean PAP, and PVR were higher in patients with severe FMR than in those without severe FMR [58.5 (48.0-70.2) versus 45.0 (36.0-64.0), p= 3 and 5 WU [odds ratio (OR): 2.0, 95% confidence interval (CI): 1.1-3.6, p=0.009; and OR: 3.2, 95% CI: 1.5-6.7, p=0.002]. The multivariate regression analysis results revealed that presence of severe FMR is an independent risk factor for PVR >= 3 WU and presence of combined pre-post-capillary PH (OR: 2.23, 95% CI: 1.30-3.82, p=0.003 and OR: 2.30, 95% CI: 1.25-4.26, p=0.008). Conclusion: Even in the updated definition of FMR with a lower threshold, severe FMR is associated with higher PVR, systolic PAP, and mean PAP and appears to have an unfavorable effect on pulmonary hemodynamics in patients with HT.

26 April 2021 in Kosuyolu Heart Journal
Verified
Journal Article
Open access
ÖAÖzgür Yaşar Akbal
Özgür Yaşar Akbal
BKBarkın Kültürsay
Barkın Kültürsay
UFUğur Fındıkçıoğlu
Uğur Fındıkçıoğlu
BKBerhan Keskin
Berhan Keskin
DÇDoğancan Çeneli
Doğancan Çeneli
CKCihangir Kaymaz
Cihangir Kaymaz

1 July 2023 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
AHAykun Hakgor
Aykun Hakgor
HDHacer Ceren Tokgoz Demircan
Hacer Ceren Tokgoz Demircan
BKBerhan Keskin
Berhan Keskin
SÜSeda TANYERİ ÜZEL
Seda TANYERİ ÜZEL
BKBarkın Kültürsay
Barkın Kültürsay
CKCihangir Kaymaz
Cihangir Kaymaz
Background: Pulmonary embolism severity index and simplified pulmonary embolism severity index have been utilized in initial risk evaluation in patients with acute pulmonary embolism. However, these models do not include any imaging measure of right ventricle function. In this study, we proposed a novel index and aimed to evaluate the clinical impact.Methods: Our study population comprised retrospectively evaluated 502 patients with acute pulmonary embolism managed with different treatment modalities. Echocardiographic and computed tomographic pulmonary angiography evaluations were performed at admission to the emergency room within maximally 30 minutes. The formula of our index was as follows: (right ventricle diameter x systolic pulmonary arterial pressure-echo)/(right ventricle free-wall diameter x tricuspid annular plane systolic excursion).Results: This index value showed significant correlations to clinical and hemodynamic severity measures. Only pulmonary embolism severity index, but not our index value, independently predicted in-hospital mortality. However, an index value higher than 17.8 predicted the long-term mortality with a sensitivity of 70% and specificity of 40% (areas under the curve = 0.652, 95% CI, 0.557-0.747, P = .001). According to the adjusted variable plot, the risk of long-term mortality increased until an index level of 30 but remained unchanged thereafter. The cumulative hazard curve also showed a higher mortality with high-index value versus low-index value.Conclusions: Our index composed from measures of computed tomographic pulmonary angiography and transthoracic echocardiography may provide important insights regarding the adaptation status of right ventricle against pressure/wall stress in acute pulmonary embolism, and a higher value seems to be associated with severity of the clinical and hemodynamic status and long-term mortality but not with in-hospital mortality. However, the pulmonary embolism severity index remained as the only independent predictor for in-hospital mortality.

26 July 2021 in Kosuyolu Heart Journal
Verified
Journal Article
Open access
ZBZubeyde Bayram
Zubeyde Bayram
SESüleyman Cagan Efe
Süleyman Cagan Efe
AKAli Karagoz
Ali Karagoz
CDCem Dogan
Cem Dogan
BSBusra Guvendi Sengor
Busra Guvendi Sengor
NONihal Ozdemir
Nihal Ozdemir
Objectives: The aim of this study was to investigate the effect of heart failure (HF) etiology on clinical, echocardiographic, and hemodynamic findings, right ventricular (RV) function, and outcomes in patients with end-stage HF. Patients and Methods: A total of 470 end-stage HF patients who undergoing evaluation for heart transplantation (HT) were divided into two groups: ischemic cardiomyopathy (ICMP, n=249) and nonischemic cardiomyopathy (NICMP, n=221). RV dysfunction was defined as tricuspid annular plane systolic excursion (TAPSE) ≤1.5 cm (TAPSE-defined RV dysfunction) and right ventricular stroke work index (RVSWI) <5 g/m/beat/m2 (RVSWI-defined RV dysfunction). The primary outcome was defined as left ventricular assist device implantation, urgent HT, or death. Results: Patients with ICMP had higher pulmonary vascular resistance, systolic and mean pulmonary artery pressures (PAPs and PAPm) than those with NICMP [3.0 (1.1-6.0) vs. 2.0 (1.0-5.0),P=0.013; 53.5 (42.0-68.0) vs. 46.0 (32.5-64.5),P <0.001 and 35.512.9 vs. 31.812.3,P=0.002]. RVSWI levels were lower in NICMP patients than in ICMP patients [5.4 (3.7-7.6) vs. 6.5 (4.6-9.6),P <0.001]. While TAPSE-defined RV dysfunction was comparable between NICMP and ICMP, RVSWI-defined RV dysfunction was higher in NICMP (44.3% vs. 55.0%,P=0.069 and 45.2% vs. 31.3%,P=0.012). NICMP was an independent predictor for RVSWI-defined RV dysfunction, but not for TAPSE-defined RV dysfunction, according to multivariate analyses (OR:1.79, 95% CI:1.13-2.82,P=0.012 and OR:0.63, 95% CI:0.28-1.39,P=0.254). Over a median follow-up of 503.5 days, it was demonstrated that HF etiology was not a predictor of primary outcome according to unadjusted and adjusted models (OR:0.99, 95% CI:0.80-1.23,P=0.936 ve OR:0.89, 95% CI:0.60-1.31,P=0.542). Conclusion: We that demonstrated patients with end-stage HF, ICMP had greater RV afterload and RVSWI value than NICMP and HF etiology was not predictor of primary outcome. However, we couldn't say for sure whether HF etiology has an effect on RV function because of the conflicting results in TAPSE-defined RV dysfunction and RVSWI-defined RV dysfunction.